Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

USG-Guided Retrolaminar Block Improves Postoperative Gastrointestinal System Functions in Percutaneous Nephrolithotomy Patients: A Prospective, Randomised, Clinical Study

NCT06787898 is registered in ClinicalTrials.gov with Elazıg Fethi Sekin Sehir Hastanesi as lead sponsor.

NCT NCT06787898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06787898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
USG-Guided Retrolaminar Block Improves Postoperative Gastrointestinal System Functions in Percutaneous Nephrolithotomy Patients: A Prospective, Randomised, Clinical Study
Lead sponsor
Elazıg Fethi Sekin Sehir Hastanesi
Phase
Not applicable
Overall status
Completed
Start date
January 22, 2025
Completion date
February 15, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

percutaneous nephrolithotomy (pcnl), retrolaminar block